Clinical trials
Phase 1/2 trials in Hong Kong
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
81 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 5 |
| 2009 | 5 |
| 2010 | 4 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 4 |
| 2018 | 5 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 6 |
| 2022 | 8 |
| 2023 | 7 |
| 2024 | 3 |
| 2025 | 4 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 43 |
| Recruiting | 17 |
| Terminated | 9 |
| Active, not recruiting | 9 |
| Unknown status | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 10 |
| Chinese University of Hong Kong | 6 |
| Puma Biotechnology, Inc. | 4 |
| Alentis Therapeutics AG | 3 |
| Bristol-Myers Squibb | 3 |
| Pfizer | 3 |
| The Hong Kong Polytechnic University | 3 |
| Amgen | 2 |
| BioAtla, Inc. | 2 |
| Cullinan Therapeutics Inc. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 16 |
| Carcinoma, Hepatocellular | 9 |
| Neoplasms | 9 |
| Breast Neoplasms | 8 |
| Lung Neoplasms | 7 |
| Head and Neck Neoplasms | 6 |
| Hepatitis B, Chronic | 6 |
| Squamous Cell Carcinoma of Head and Neck | 5 |
| Carcinoma | 4 |
| Colorectal Neoplasms | 4 |
Trials
Showing 26 to 50 of 81. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.